Literature DB >> 15385454

Polymorphism and transcription at the p44-1/p44-18 genomic locus in Anaplasma phagocytophilum strains from diverse geographic regions.

Quan Lin1, Yasuko Rikihisa, Robert F Massung, Zerai Woldehiwet, Richard C Falco.   

Abstract

A polymorphic multigene family (p44) of Anaplasma phagocytophilum encodes the immunodominant 44-kDa major outer membrane proteins. With p44-specific PCR and gene-specific probes, p44-1 was found in all human isolates from New York State but not in isolates from Minnesota, whereas p44-18 and two other p44 species were found in isolates from both regions. We therefore sequenced the genomic locus corresponding to the p44-1/p44-18 tandem locus of A. phagocytophilum HZ in 14 other geographically divergent strains from various hosts. The locus was found in all 14 strains, and p44-18 was conserved among all 13 United States isolates studied. In all nine northeastern strains, p44-1 was conserved. However, in three of the Minnesota strains and in one California strain, p44-1 was replaced at this genomic locus by the novel gene p44-61 (p44-61/18), whose hypervariable region (hv) was a chimera of p44-20hv and p44-23hv. The conserved base sequence within the hv region linked the two segments. In contrast, in the Old Sourhope strain isolated from sheep in the United Kingdom, only a single and distinct p44, p44-OS, was found in this locus. This suggests different rates of evolution of p44-1 and p44-18 at this locus and conservation of the locus within strains isolated from the same geographic region. Locus-specific reverse transcription-PCR revealed expression of p44-1 by New York and p44-61 by Minnesota strains at this locus. These p44 loci provide insight into the molecular evolution and functional divergence of p44 paralogs and may serve as markers for typing strains from different geographic regions.

Entities:  

Mesh:

Year:  2004        PMID: 15385454      PMCID: PMC517535          DOI: 10.1128/IAI.72.10.5574-5581.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Comparison of the nucleotide sequences of 16S rRNA, 444 Ep-ank, and groESL heat shock operon genes in naturally occurring Ehrlichia equi and human granulocytic ehrlichiosis agent isolates from Northern California.

Authors:  J S Chae; J E Foley; J S Dumler; J E Madigan
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Molecular typing of the etiologic agent of human granulocytic ehrlichiosis.

Authors:  S E Carter; M D Ravyn; Y Xu; R C Johnson
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Sequence analysis of the ank gene of granulocytic ehrlichiae.

Authors:  R F Massung; J H Owens; D Ross; K D Reed; M Petrovec; A Bjoersdorff; R T Coughlin; G A Beltz; C I Murphy
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks.

Authors:  Ning Zhi; Norio Ohashi; Tomoko Tajima; Jason Mott; Roger W Stich; Debra Grover; Sam R Telford; Quan Lin; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients.

Authors:  Quan Lin; Ning Zhi; Norio Ohashi; Harold W Horowitz; Maria E Aguero-Rosenfeld; John Raffalli; Gary P Wormser; Yasuko Rikihisa
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 6.  Human granulocytic ehrlichiosis in Europe.

Authors:  J R Blanco; J A Oteo
Journal:  Clin Microbiol Infect       Date:  2002-12       Impact factor: 8.067

7.  Analyses of Ehrlichia canis and a canine granulocytic Ehrlichia infection.

Authors:  Y Rikihisa; S A Ewing; J C Fox; A G Siregar; F H Pasaribu; M B Malole
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

8.  Activation of a p44 pseudogene in Anaplasma phagocytophila by bacterial RNA splicing: a novel mechanism for post-transcriptional regulation of a multigene family encoding immunodominant major outer membrane proteins.

Authors:  Ning Zhi; Norio Ohashi; Yasuko Rikihisa
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

9.  Differential expression of the p44 gene family in the agent of human granulocytic ehrlichiosis.

Authors:  Jacob W IJdo; Caiyun Wu; Sam R Telford; Erol Fikrig
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Genetic variants of Ehrlichia phagocytophila, Rhode Island and Connecticut.

Authors:  Robert F Massung; Michael J Mauel; Jessica H Owens; Nancy Allan; Joshua W Courtney; Kirby C Stafford; Thomas N Mather
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

View more
  10 in total

Review 1.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Porin activity of Anaplasma phagocytophilum outer membrane fraction and purified P44.

Authors:  Haibin Huang; Xueqi Wang; Takane Kikuchi; Yumi Kumagai; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2006-12-15       Impact factor: 3.490

3.  Genetic variants of Anaplasma phagocytophilum from 14 equine granulocytic anaplasmosis cases.

Authors:  Cornelia Silaghi; Gabriele Liebisch; Kurt Pfister
Journal:  Parasit Vectors       Date:  2011-08-16       Impact factor: 3.876

4.  Two monoclonal antibodies with defined epitopes of P44 major surface proteins neutralize Anaplasma phagocytophilum by distinct mechanisms.

Authors:  Xueqi Wang; Takane Kikuchi; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

5.  Anaplasma phagocytophilum p44 mRNA expression is differentially regulated in mammalian and tick host cells: involvement of the DNA binding protein ApxR.

Authors:  Xueqi Wang; Zhihui Cheng; Chunbin Zhang; Takane Kikuchi; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2007-09-28       Impact factor: 3.490

6.  High-resolution genetic fingerprinting of European strains of Anaplasma phagocytophilum by use of multilocus variable-number tandem-repeat analysis.

Authors:  Kevin J Bown; Xavier Lambin; Nicholas H Ogden; Miroslav Petrovec; Susan E Shaw; Zerai Woldehiwet; Richard J Birtles
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

7.  Global proteomic analysis of two tick-borne emerging zoonotic agents: anaplasma phagocytophilum and ehrlichia chaffeensis.

Authors:  Mingqun Lin; Takane Kikuchi; Heather M Brewer; Angela D Norbeck; Yasuko Rikihisa
Journal:  Front Microbiol       Date:  2011-02-17       Impact factor: 5.640

8.  Epidemiology, genetic variants and clinical course of natural infections with Anaplasma phagocytophilum in a dairy cattle herd.

Authors:  Cornelia Silaghi; Marion Nieder; Carola Sauter-Louis; Gabriela Knubben-Schweizer; Kurt Pfister; Martin Pfeffer
Journal:  Parasit Vectors       Date:  2018-01-08       Impact factor: 3.876

9.  Comparative genomics of emerging human ehrlichiosis agents.

Authors:  Julie C Dunning Hotopp; Mingqun Lin; Ramana Madupu; Jonathan Crabtree; Samuel V Angiuoli; Jonathan A Eisen; Jonathan Eisen; Rekha Seshadri; Qinghu Ren; Martin Wu; Teresa R Utterback; Shannon Smith; Matthew Lewis; Hoda Khouri; Chunbin Zhang; Hua Niu; Quan Lin; Norio Ohashi; Ning Zhi; William Nelson; Lauren M Brinkac; Robert J Dodson; M J Rosovitz; Jaideep Sundaram; Sean C Daugherty; Tanja Davidsen; Anthony S Durkin; Michelle Gwinn; Daniel H Haft; Jeremy D Selengut; Steven A Sullivan; Nikhat Zafar; Liwei Zhou; Faiza Benahmed; Heather Forberger; Rebecca Halpin; Stephanie Mulligan; Jeffrey Robinson; Owen White; Yasuko Rikihisa; Hervé Tettelin
Journal:  PLoS Genet       Date:  2006-02-17       Impact factor: 5.917

10.  Molecular characterization of Msp2/P44 of Anaplasma phagocytophilum isolated from infected patients and Haemaphysalis longicornis in Laizhou Bay, Shandong Province, China.

Authors:  Yong Wang; Chuangfu Chen; Lijuan Zhang
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.